Bacterial Physiology (Micr430) Lecture 10 Macromolecular Synthesis: Cell Wall (Text Chapter: 11)

Slides:



Advertisements
Similar presentations
Beta-Lactamase Inhibitors
Advertisements

Antimicrobials: Drugs that Weaken the Cell Wall
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 84 Drugs That Weaken the Bacterial Cell Wall I: Penicillins.
And Penicillins.  Though antimicrobials have been around forever, we have only known about them since the late 1920’s.  A fungal contaminant on a bacterial.
Antibiotics.
 Cefixime is quickly establishing in Western countries as a potent broad-spectrum antibiotic with a variety of indications. A multinational, nonrandomized.
Pharmacology-1 PHL nd Term 10 th Lecture By Abdelkader Ashour, Ph.D. Phone:
DENS 521 Clinical Dental Therapeutics
Advanced Microbial Physiology Lecture 2 Cell Wall Biosynthesis.
Pharmacology-1 PHL nd Term 9 th Lecture By Abdelkader Ashour, Ph.D. Phone:
Antibiotics Review 10 August :39 AM.
Antibiotics and inhibition of cell wall in bacteria.
Bacterial Cell Wall Inhibitors
Antibiotics; Inhibitors of Cell Wall Synthesis LECTURE 10: Microbiology and Virology; 3 Credit hours Atta-ur-Rahman School of Applied Biosciences (ASAB)
ß -lactam antibiotics Liming Zhou Department of pharmacology.
Gram Negative Gram Positive
ANTIBIOTICS LauraLe Dyner MD Pediatric Infectious Disease Fellow March 2009.
COL Helen Viscount, PhD, D(ABMM) LTC Steven Mahlen, PhD, D(ABMM)
PENICILLINS  One of the most important groups of antibiotics.  They are still widely used.  Drugs of choice for a large number of infectious diseases.
Antibiotics 101 Puja Van Epps 1/20/14.
Mechanisms of antimicrobial action directed against the bacterial cell wall and corresponding resistance mechanisms M-4 Advanced Therapeutics Course.
Beta lactam antibiotics & Other cell wall synthesis inhibitors
DHS/PP Antimicrobial Therapy David H. Spach, MD Professor of Medicine Division of Infectious Diseases University of Washington, Seattle.
Clinical Cases Beta-Lactam Answers. Case 1 What antibiotic would you recommend for intravenous therapy in a 40yo BM with a Staphylococcus aureus (MSSA)
Staphylococcus aureus…………quickly posed a problem
BETA-LACTAM ANTIMICROBIAL AGENTS Alan M. Stamm, M.D. October 23, 2002.
CELL WALL SYNTHESIS INHIBITORS
Penicillin and Cephalosprin: Beta- Lactam Antibiotics and Other Inhibitors of Cell Wall Synthesis by Dena Nguyen
AMINOGLYCOSIDES The different members of this group share many properties in common. The different members of this group share many properties in common.
Cell Wall Synthesis Inhibitors By S.Bohlooli, PhD.
Beta lactams. INHIBITORS OF CELL WALL SYNTHESIS Natural: Pencillinase Resistant: (Anti staph) 1)Benzyl pencillin (G) k+ Na+1) oxcillin 2)Procaine pencillin.
PENICILLINS Dr. Naila Abrar. LEARNING OBJECTIVES After this session you should be able to:  know the source & chemistry of penicillins;  recall the.
CHEMOTHERAPEUTICS OF INFECTIOUS DISEASES Anton Kohút.
Cell walls.
Case 1  Tunyapon Sasithorn Pharmacology Clinical case.
DENS 521 Clinical Dental Therapeutics
PENICILLINS Beta- lactam antibiotics Derivatives of 6- aminopenicillanic acid Alteration of the side group resulted in cpds with : Broader spectrum of.
Antimicrobial drugs. Antimicrobial drugs are effective in the treatment of infections because of their selective toxicity (that is, they have the ability.
Inhibitors of cell wall synthesis (β-Lactam Antibiotics )
1 Drugs that Inhibit Cell wall synthesis Beta-lactams –Penicillin family –Cephalosporin family –Carbapenems and Monobactams –Β-lactamase inhibitors Vancomycin.
Chapter 21 Antimicrobial medications Biology 261 Prof. Santos Medgar Evers College.
Antimicrobial Agents & Mechanisms of Resistance BY Prof. DR. Zainalabideen A. Abdulla, DTM&H., MRCPI, Ph.D., FRCPath. (U.K.)
 Antibiotics (Greek anti, “against”; bios, “life”) are chemical compounds used to kill or inhibit the growth of infectious organisms. Originally the.
Dr. Laila M. Matalqah Ph.D. Pharmacology Principle of Antimicrobial & Cell Wall inhibitors General Pharmacology M212.
DENS 521 Clinical Dental Therapeutics 2 nd Lecture By Abdelkader Ashour, Ph.D. Phone:
Dr. Laila M. Matalqah Ph.D. Pharmacology
Beta-Lactam antibiotics & Other Cell Wall Synthesis Inhibitors
4/28/2017 AST.
PRINCIPLES OF ANTIBIOTIC THERAPY
Antibiotics; Inhibitors of Cell Wall Synthesis
Principles of Medical Science Pharmacology Review
Cephalosporins Four Generations! Bactericidal & Time-Dependent!
Drugs used in Meningitis Prof. M. Alhumayyd
Bacterial cell envelope and antibiotics efficacy
Cell wall inhibitor Cephalosporins Dr. Naza M. Ali Lec D
Site of Action of Antibiotics
Drugs /Agents Inhibitors of cell wall synthesis
An Introduction to Medicinal Chemistry 3/e
Pencillins.
Cephalosporin and Other Cell Wall Synthesis Inhibitors
Cell Wall Synthesis Inhibitors (Penicillins)
Cephalosporin and Cell Wall Synthesis Inhibitors
Drugs that Inhibit Cell wall synthesis
Cell Wall Inhibitors.
Cell Wall Synthesis Inhibitors (Penicillins)
Chemotherapeutic Medicine
Cephalosporin and Cell Wall Synthesis Inhibitors
β- Lactamase Inhibitor
-Lactam Antibiotics: Penicillins
Cell Wall Synthesis Inhibitors (Penicillins)
Presentation transcript:

Bacterial Physiology (Micr430) Lecture 10 Macromolecular Synthesis: Cell Wall (Text Chapter: 11)

Peptidoglycan Review Cell wall is composed of peptidoglycan. N-acetylmuramic acid is unique to bacterial cell wall; it cannot be found in any other cell types or organisms. Peptidoglycan is made of glycan strands of alternating residues of N- acetylmuramic acid and N- aetylglucosamine linked by  -1,4 bond.

Fig. 11.2

Peptidoglycan Review These glycan strands are cross-linked by amino acids. Attached to each N-acetylmuramic acid is a tetrapeptide in the following order: L-alanyl-D-glutamyl-  -L-R3-D-alanine. Peptidoglycan confers strength to the cell wall.

Fig. 11.3

Peptidoglycan Synthesis Peptidoglycan is made in four stages: Precursor formation (in cytoplasm) involving UDP derivatives of amino sugars Transfer through membrane. Polymerization on outer surface of membrane A transpeptidation reaction cross-links the peptidoglycan.

Fig. 11.4

Fig. 11.6

Fig. 11.7

phosphomycin cycloserine penicillins tunicamycin

Inhibitors of cell wall biosynthesis

Beta-Lactam Structure

 -Lactam Characteristics Same MOA: Inhibit cell wall synthesis Bactericidal (except against Enterococcus sp.); time-dependent killers Short elimination half-life Primarily renally eliminated (except nafcillin, oxacillin, ceftriaxone, cefoperazone) Cross-allergenicity - except aztreonam

ALL  -lactams Mechanism of Action z interfere with cell wall biosynthesis by binding to penicillin-binding proteins (PBPs) which are located in bacterial cell walls z inhibition of PBPs leads to inhibition of peptidoglycan synthesis z are bactericidal

Penicillins Natural Penicillins (penicillin G, penicillin VK) Penicillinase-Resistant Penicillins (nafcillin, oxacillin, methicillin) Developed to overcome the penicillinase enzyme of S. aureus which inactivated natural penicillins Aminopenicillins (ampicillin, amoxicillin) Developed to increase activity against gram-negative aerobes Carboxypenicillins (carbenicillin, ticarcillin) and Ureidopenicillins (piperacillin, azlocillin) Developed to further increase activity against resistant gram-negative aerobes  -Lactamase Inhibitor Combos (Unasyn, Augmentin, Timentin, Zosyn) Developed to gain or enhance activity against  - lactamase producing organisms

Cephalosporins Divided into 4 major groups called “Generations” based on z antimicrobial activity z resistance to beta-lactamase

Monobactams Spectrum of Activity Aztreonam bind preferentially to PBP 3 of gram-negative aerobes; has little to no activity against gram-positives or anaerobes Gram-negative E. coli, K. pneumoniae, P. mirabilis, S. marcescens H. influenzae, M. catarrhalis Enterobacter, Citrobacter, Providencia, Morganella Salmonella, Shigella Pseudomonas aeruginosa

Carbapenems Spectrum of Activity Most broad spectrum of activity of all antimicrobials Have activity against gram-positive and gram-negative aerobes and anaerobes Bacteria not covered by carbapenems include MRSA, VRE, coagulase-negative staph, C. difficile, S. maltophilia, Nocardia

Vancomycin Complex tricyclic glycopeptide produced by Nocardia orientalis, MW = 1500 Da Commercially-available since 1956 Current product has been extensively purified - decreased adverse effects Clinical use decreased with introduction of antistaphylococcal penicillins Today, use increasing due to emergence of resistant bacteria (MRSA)

Vancomycin Structure

Vancomycin Mechanism of Action Inhibits bacterial cell wall biosynthesis at a site different than beta-lactams Inhibits synthesis and assembly of the second stage of peptidoglycan polymers Binds firmly to D-alanyl-D-alanine portion of cell wall precursors Bactericidal (except for Enterococcus)

Vancomycin Spectrum of Activity Gram-positive bacteria Methicillin-Susceptible AND Methicillin-Resistant S. aureus and coagulase-negative staphylococci Streptococcus pneumoniae (including PRSP), viridans streptococcus, Group B streptococcus Enterococcus sp. Corynebacterium, Bacillus. Listeria, Actinomyces Clostridium sp. (including C. difficile), Peptococcus, Peptostreptococcus No activity against gram-negative aerobes or anaerobes